Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1982 1
1984 1
1986 1
1988 1
1989 2
1991 1
1992 1
1994 1
1995 3
1996 1
1997 3
1998 1
2000 1
2001 1
2002 1
2003 1
2004 1
2005 2
2006 4
2007 4
2008 8
2009 4
2010 1
2011 4
2012 5
2013 7
2014 8
2015 5
2016 11
2017 5
2018 5
2019 8
2020 4
2021 1
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS, Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM, Benigno B, Arora S, Hazard SJ, Mirza MR. Del Campo JM, et al. J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173551 Free PMC article. Clinical Trial.
MicroRNAs as prognostic markers in ovarian cancer.
Llauradó M, Majem B, Altadill T, Lanau L, Castellví J, Sánchez-Iglesias JL, Cabrera S, De la Torre J, Díaz-Feijoo B, Pérez-Benavente A, Colás E, Olivan M, Doll A, Alameda F, Matias-Guiu X, Moreno-Bueno G, Carey MS, Del Campo JM, Gil-Moreno A, Reventós J, Rigau M. Llauradó M, et al. Among authors: del campo jm. Mol Cell Endocrinol. 2014 Jun 5;390(1-2):73-84. doi: 10.1016/j.mce.2014.03.006. Epub 2014 Apr 18. Mol Cell Endocrinol. 2014. PMID: 24747602 Review.
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
Grisham RN, Vergote I, Banerjee S, Drill E, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Cibula D, Moore KN, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Kristensen G, Clamp A, Farley J, Iyer G, Ray-Coquard I, Monk BJ. Grisham RN, et al. Among authors: del campo jm. Clin Cancer Res. 2023 Oct 13;29(20):4068-4075. doi: 10.1158/1078-0432.CCR-23-0621. Clin Cancer Res. 2023. PMID: 37581616 Free PMC article.
Discussion: session 1.
Sehouli J, del Campo JM, Lorusso D. Sehouli J, et al. Among authors: del campo jm. Future Oncol. 2013 Dec;9(12 Suppl):25-7. doi: 10.2217/fon.13.201. Future Oncol. 2013. PMID: 24195527 No abstract available.
Mitomycin-C and vinblastine in advanced breast cancer.
Navarro M, Bellmunt J, Balañá C, Colomer R, Jolis L, del Campo JM. Navarro M, et al. Among authors: del campo jm. Oncology. 1989;46(3):137-42. doi: 10.1159/000226702. Oncology. 1989. PMID: 2497417 Review.
Novel Hydrogen Bioreactor and Detection Apparatus.
Rollin JA, Ye X, Del Campo JM, Adams MW, Zhang YH. Rollin JA, et al. Among authors: del campo jm. Adv Biochem Eng Biotechnol. 2016;152:35-51. doi: 10.1007/10_2014_274. Adv Biochem Eng Biotechnol. 2016. PMID: 25022362
Self-Consistent Auxiliary Density Perturbation Theory.
Delesma FA, Delgado-Venegas RI, Salahub DR, Del Campo JM, Pedroza-Montero JN, Calaminici P, Köster AM. Delesma FA, et al. Among authors: del campo jm. J Chem Theory Comput. 2021 Nov 9;17(11):6934-6946. doi: 10.1021/acs.jctc.1c00713. Epub 2021 Oct 28. J Chem Theory Comput. 2021. PMID: 34709812
107 results